A reanalysis of Sweden’s population-based fecal occult blood test (FOBT) screening program suggests that the mortality benefit of colorectal cancer…
Browsing: Clinical Updates
BioNTech is ending a mid-stage trial of its experimental personalized mRNA cancer vaccine, autogene cevumeran, after an independent committee concluded…
Researchers at Nanyang Technological University developed peptide microdroplets that deliver siRNA into T cells and colorectal cancer cells to suppress…
New studies suggest that physical activity may decline rather than increase after starting GLP-1 medications, despite recommendations to exercise to…
Carelon Health Services will add Guardant Health’s Shield blood test to its colorectal cancer screening coverage guidelines effective Nov. 15,…
Guardant Health’s Shield blood test has already been used by hundreds of thousands of people since its 2025 launch, with…
This multicentre, three-armed non-inferiority randomised controlled trial (RCT) included patients with IBS (Rome IV, 16–75 years). Patients were randomised to…
A real-world study of 219 adults with suspected IBS found that patients who underwent IBS-Smart and/or Trio-Smart testing had lower…
A 21-year population-level analysis from Spain’s Basque Country found that an organized fecal immunochemical test (FIT) screening program was associated…
Researchers at Yonsei University have identified a microbial signature in saliva that could help distinguish people with gastrointestinal cancers, including…